Swissmedic erteilt Basileas Antibiotikum Zevtera® (Ceftobiprol Medocaril) die Zulassung zur Behandlung von Lungenentzündung - Seite 4
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Basilea Pharmaceutica AG via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Basilea Pharmaceutica AG via Globenewswire
HUG#1882293
Lesen Sie auch
--- Ende der Mitteilung ---
Basilea Pharmaceutica AG
Grenzacherstrasse 487 Basel Schweiz
Notiert: Freiverkehr in Börse Stuttgart,
Freiverkehr in Börse Berlin,
Open Market (Freiverkehr) in Frankfurter Wertpapierbörse,
Freiverkehr in Bayerische Börse München;
Aktuelle Themen
1 im Artikel enthaltener WertIm Artikel enthaltene Werte